Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Neurochemicals of Limbic System and Thalamofrontal Cortical Network: Are They Different Between Patients With Idiopathic Generalized Epilepsy and Psychogenic Nonepileptic Seizure?
Vajiheh Aghamollaii
Vajiheh Aghamollaii

Associate Professor of Neurology

Department Psychiatry

School of Medicine

Roozbeh Hospital

Tehran University of Medical Sciences

Related Documents
1. A Systematic Review of Resting-State and Task-Based Fmri in Juvenile Myoclonic Epilepsy, Brain Imaging and Behavior (2022)
All Documents
1. Comparison of Quantitative-Electroencephalogram (Q-Eeg) Measurements Between Patients of Dementia With Lewy Bodies (Dlb) and Parkinson Disease Dementia (Pdd), Clinical EEG and Neuroscience (2025)
2. [99Mtc]Tc-Trodat-1 Scan Diagnostic Accuracy for Differentiation of Dementia of Lewy Body From Alzheimer's Disease, Iranian Journal of Nuclear Medicine (2024)
3. Depression Is Associated With the Nonmotor Symptoms of Parkinson's Disease: A Comparative Analysis, Health Science Reports (2024)
4. Evaluating Efficacy and Safety of Saffron Add-On Treatment in Improvement of Motor and Depressive Symptoms of Patients With Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Journal of Herbal Medicine (2024)
5. Investigating Noun and Verb Naming in Behavioral Variant of Frontotemporal Dementia and Non-Patients Persian-Speaking, Journal of Modern Rehabilitation (2024)
6. Lysine Ε-Aminolysis and Incorporation of Sulfhydryl Groups Into Human Brain Tau 4R/1N and 306Vqivyk311 Enhances the Formation of Beta Structures and Toxicity, International Journal of Biological Macromolecules (2024)
7. Therapeutic Potential of the Ketogenic Diet: A Metabolic Switch With Implications for Neurological Disorders, the Gut-Brain Axis, and Cardiovascular Diseases, Journal of Nutritional Biochemistry (2024)
8. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients With Mild to Moderate Alzheimer's Disease, Journal of Alzheimer's Disease (2023)
9. Combination of Vestibular Rehabilitation and Galvanic Vestibular Stimulation Improves Verbal and Visuospatial Memory: A Randomized Control Trial in Patients With Amnestic Mild Cognitive Impairment, Auditory and Vestibular Research (2023)
10. Onset of Mania by Vitamin B12 Injection in a 52-Year Old Patient With Refractory and Resistant Depression, Journal of Nutrition and Food Security (2023)
11. Plasma Cytokines Profile in Patients With Alzheimer’S and Parkinson’S Disease: A Comparative Study in Terms of Inflammation, International Journal of Neuroscience (2023)
12. The Effect of Cannabidiol on Seizure Features and Quality of Life in Drug-Resistant Frontal Lobe Epilepsy Patients: A Triple-Blind Controlled Trial, Frontiers in Neurology (2023)
13. Thyroid Hormone Levels in Alzheimer Disease: A Systematic Review and Meta-Analysis, Endocrine (2023)
14. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients With Multiple Sclerosis: A Study of Diagnostic Accuracy, Archives of Clinical Neuropsychology (2023)
15. Valproic Acid–Induced Hyperammonemia in Neuropsychiatric Disorders: A 2-Year Clinical Survey, Psychopharmacology (2023)
16. A Systematic Review of Resting-State and Task-Based Fmri in Juvenile Myoclonic Epilepsy, Brain Imaging and Behavior (2022)
17. Boswellia Serrata Extract Shows Cognitive Benefits in a Double-Blind, Randomized, Placebo-Controlled Pilot Clinical Trial in Individuals Who Suffered Traumatic Brain Injury, Brain Injury (2022)
18. Psychometric Evaluation of Persian Version of Seizure Severity Questionnaire, Epilepsy and Behavior (2022)
19. Safety and Efficacy of Melatonin, Clonazepam, and Trazodone in Patients With Parkinson’S Disease and Sleep Disorders: A Randomized, Double-Blind Trial, Neurological Sciences (2022)
20. Safety and Efficacy of Memantine in Improving Cognitive Function of Patients With Epilepsy, Caspian Journal of Neurological Sciences (2022)
21. The Potential Role of the Cardiac Mibg Scan in Differentiating the Drug-Induced Parkinsonism From Parkinson's Disease, Clinical Parkinsonism and Related Disorders (2022)
22. Challenges in Corticosteroid Dose Regulation in a Patient With Autoimmune Thyroid Disease and Neuropsychiatric Syndrome: A Running Commentary, Clinical Case Reports (2021)
23. Cognitive Impairment in Opium Use Disorder, Behavioural Neurology (2021)
24. Idiopathic Superficial Siderosis of the Central Nervous System, Cerebellum and Ataxias (2021)
25. Chronic Neurological Diseases and Covid-19: Associations and Considerations, Translational Neuroscience (2020)
26. Conformational Change and Gtpase Activity of Human Tubulin: A Comparative Study on Alzheimer’S Disease and Healthy Brain, Journal of Neurochemistry (2020)
27. Evaluating Executive Functions in Patients With Juvenile Myoclonic Epilepsy Using Frontal Assessment Battery, Behavioural Neurology (2020)
28. Safety and Efficacy of Memantine for Multiple Sclerosis-Related Fatigue: A Pilot Randomized, Double-Blind Placebo-Controlled Trial, Journal of the Neurological Sciences (2020)
29. Vitamin D Level in Alzheimer's Disease: A Case Control Study, Tehran University Medical Journal (2020)
30. A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy, CNS Drugs (2019)
31. Association of Depression With Migraine Without Aura; a Cross-Sectional Study, Clinical Neuropsychiatry (2019)
32. Catatonic State As a Rare Presentation of Neurobrucellosis: A Case Report, Iranian Journal of Psychiatry and Behavioral Sciences (2019)
33. Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5), CNS Drugs (2019)
34. Functional Improvement and Immune-Inflammatory Cytokines Profile of Ischaemic Stroke Patients After Treatment With Boswellic Acids: A Randomized, Double-Blind, Placebo-Controlled, Pilot Trial, Inflammopharmacology (2019)
35. Plasma Levels of Brain-Derived Neurotrophic Factor in Patients With Parkinson Disease: A Systematic Review and Meta-Analysis, Brain Research (2019)
36. Plasma Neurofilament Light Chain Levels Are Associated With Cortical Hypometabolism in Alzheimer Disease Signature Regions, Journal of Neuropathology and Experimental Neurology (2019)
37. Biphasic Effect of Sumatriptan on Ptz-Induced Seizures in Mice: Modulation by 5-Ht1b/D Receptors and Nos/No Pathway, European Journal of Pharmacology (2018)
38. Safety and Efficacy of Nanocurcumin As Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial, Neurotherapeutics (2018)
39. Treatment of Myoclonus–Dystonia With Carbamazepine, Parkinsonism and Related Disorders (2018)
40. Evaluating Executive Function in Patients With Temporal Lobe Epilepsy Using the Frontal Assessment Battery, Epilepsy Research (2017)
41. Potential Diagnostic Value of 131I-Mibg Myocardial Scintigraphy in Discrimination Between Alzheimer Disease and Dementia With Lewy Bodies, Clinical Neurology and Neurosurgery (2017)
42. Ptrhd1 (C2orf79) Mutations Lead to Autosomal-Recessive Intellectual Disability and Parkinsonism, Movement Disorders (2017)
43. Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces, Journal of Alzheimer's Disease (2017)
44. Attentional Bias Towards and Away From Fearful Faces Is Modulated by Developmental Amygdala Damage, Cortex (2016)
45. Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study, Headache (2016)
46. Seroprevalence of Nmo-Igg Antibody in Neuromyelitis Optica (Nmo) and Its Specificity in Differentiating Nmo From Other Demyelinating Diseases With Overlap Symptoms: An Iranian Experience, Iranian Journal of Allergy# Asthma and Immunology (2015)